Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
MR Mehra et al, NEJM, MAY 1, 2020
MR Mehra et al, NEJM, MAY 1, 2020
SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance (SPHERES)
CDC, May 1, 2020
CDC, May 1, 2020
This CDC initiative will help monitor important changes in the virus as it continues to circulate, gain important insights to support contact tracing, provide crucial information to aid in identifying diagnostic and therapeutic targets, and advance public health research in the areas of transmission dynamics, host response, and evolution of the virus.
Tracing Back the Temporal Change of SARS-Cov-2 with Genomic Signatures
S Biswas et al, BIORXIV, April 30, 2020
S Biswas et al, BIORXIV, April 30, 2020
A Rapid COVID-19 RT-PCR Detection Assay for Low Resource Settings
A Arumugam et al, BIORXIV, April 30, 2020
A Arumugam et al, BIORXIV, April 30, 2020
Coronavirus Mutations Map the Global Outbreak- The pandemic left a genetic trail of clues as it spread, allowing scientists to track the source and path of the virus
WSJ, April 30, 2020
WSJ, April 30, 2020
Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements and Prognosis of COVID-19 Pneumonia Using Computed Tomography
K Zhang et al, Cell, April 30, 2020
K Zhang et al, Cell, April 30, 2020
Rapid identification of high-risk patients for early intervention is challenging. Using a large computed Tomography (CT) database from 4,154 patients, we developed an AI system that can diagnose NCP and differentiate it from other common pneumonia and normal controls.
Genetic structure of SARS-CoV-2 in Western Germany reflects clonal superspreading and multiple independent introduction events
A Walker et al, BIORXIV, April 29, 2020
A Walker et al, BIORXIV, April 29, 2020
Emergence of multiple variants of SARS-CoV-2 with signature structural changes
D Bhomick et al, BIORXIV, April 29, 2020
D Bhomick et al, BIORXIV, April 29, 2020
Labs Across U.S. Join Federal Initiative to Study Coronavirus Genome
New York Times, April 30, 2020
New York Times, April 30, 2020
No hay comentarios:
Publicar un comentario